Results 171 to 180 of about 1,833,102 (295)

Pregnancy-associated dense deposit disease with neurological complications caused by Salmonella Typhi: A case report. [PDF]

Qatar Med J
German S, Tarique D, Waqar T, Bhatti SI, Raja H, Khowaja L.   +5 more
europepmc   +1 more source

Rates and causes of neonatal and under-five mortality: insights from a national household survey in Pakistan. [PDF]

J Glob Health
Malik AA, Ariff S, Umer M, Nooruddin S, Habib MA, Rizvi A, Chauhadry IA, Soofi SB, Kalter HD, Black RE, Bhutta ZA.   +10 more
europepmc   +1 more source

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development

Epilepsia, EarlyView.
Abstract This article summarizes data for 13 investigational treatments for which at least preliminary seizure outcome data in patients with epilepsy were reported at the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices held in Madrid, Spain, on May 3–6, 2026.
Meir Bialer, Cecilie Johannessen Landmark, Matthias J. Koepp, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White, Elaine Wirrell   +7 more
wiley   +1 more source

Trypanosoma cruzi infection in pregnancy: New approaches to address the diagnosis and follow-up of women and newborns. [PDF]

PLoS Negl Trop Dis
Carlier Y, Alger J, Dumonteil E, Herrera C, Schijman AG, Buekens P.   +5 more
europepmc   +1 more source

Low‐intensity focused ultrasound neuromodulation for drug‐resistant epilepsy: A randomized, sham‐controlled crossover trial

Epilepsia, EarlyView.
Abstract Objective This study was undertaken to evaluate the safety, feasibility, and efficacy of low‐intensity focused ultrasound (LIFU) as a noninvasive neuromodulation technique in patients with drug‐resistant epilepsy (DRE). Methods In this pilot, single‐blind, randomized sham‐controlled crossover trial, 12 patients with DRE underwent both LIFU and
Chien‐Chen Chou, Yen‐Cheng Shih, Yi‐Hsiu Chen, Po‐Tso Lin, Chun‐Fu Lin, Po‐Chun Chu, Hao‐Li Liu, Cheng‐Chia Lee, Hsiang‐Yu Yu   +8 more
wiley   +1 more source

Obstetric Management and Outcomes for Women Living With HIV in Western Australia: A 30 Year Review. [PDF]

Aust N Z J Obstet Gynaecol
O'Donovan K, Warner TM, Nathan E, Nathan E, Nolan D, Wilson M, Dickinson JE.   +6 more
europepmc   +1 more source

Clinical Analysis of a Case of Early Treatment of Infectious Shock in Pregnancy Complicated with Disseminated Intravascular Coagulation

Advances in Clinical Medicine, 2023
openaire   +1 more source

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

Epilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang, Emilio Perucca, Samuel F. Berkovic, Piero Perucca   +3 more
wiley   +1 more source

IMPAACT 2041: Designing the Study of Glecaprevir/Pibrentasvir Treatment During Pregnancy. [PDF]

Open Forum Infect Dis
Jhaveri R, Brooks KM, Mainella V, Marcinak J, Chen MJ, McCarthy K, Tierney C, Zhang ZJ, Nelson BS, Flynn PM, Furukawa N, Eke AC, IMPAACT 2041 Protocol Team.   +12 more
europepmc   +1 more source

Prenatal betamethasone–postnatal N‐methyl‐D‐aspartic acid model of spasms: Update on mechanisms and treatments

Epilepsia Open, EarlyView.
Abstract Infantile epilepsy spasms syndrome (IESS), formerly known as infantile spasms or West Syndrome, is a severe epilepsy syndrome affecting about 3 in 10,000 newborns in the United States. Characterized by clusters of epileptic spasms, interictal hypsarrhythmia, and developmental delays, IESS has diverse causes, including structural‐metabolic ...
Kayla Vieira, Antonia Schonwald, Chian‐Ru Chern, Kamya Shah, Jana Velíšková, Libor Velíšek   +5 more
wiley   +1 more source